Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

IFG FOCUSES ON NICHE PRODUCTS AND REDUCES PRODUCTION CAPACITY IN ENGLAND

February 17, 2021      Duroc's portfolio company International Fibres Group (IFG) is strengthening its focus on niche products with higher growth potential in accordance with the group’s strategic plan. As a consequence, production capacity is being restructured and streamlined, and as a result the production facility in Drighlington will be closed down. Parts of the production will be moved to other production facilities in Europe.    The last day of operation in Drighlington will be the end of June 2021. Following the closure, IFG will have three production facilities located in

Salipro Biotech Awarded European Patent for Direct Extraction of Membrane Proteins and Library Generation

Salipro® platform technology strengthened to accelerate discovery programs for therapeutic antibodies and small molecule drugs against challenging drug targetsStockholm, Sweden, February 17, 2021 –Swedish biotech company Salipro Biotech AB today announced that the European Patent Office has issued the European Patent No. 3463303, titled “Saposin lipoprotein particles and libraries from crude membranes”. The patent covers the company’s novel method of direct extraction of membrane proteins (DirectMX™) from cells or crude membranes to enable drug development for challenging drug targets, as

FREYR receives NOK 39 million development grant from Innovation Norway

Innovation Norway, the Norwegian Government’s key instrument for supporting innovation and development of Norwegian enterprises and industry has granted FREYR NOK 39 million in development support. The grant is provided in the “environmental technology” category and relates to Innovation Norway’s task of stimulating research and development projects, domestic value generation and creation of responsible businesses. The grant is expected to be paid during 2021 and follows an evaluation process which started in the fall of 2020. FREYR is targeting development of up to 43 GWh of cost

Bio-Works signs licensing agreement with Amicogen Inc to establish local manufacturing of agarose resins in South Korea

· Bio-Works Technologies AB has signed a licensing agreement with Amicogen Inc to establish local production of agarose resins in South Korea  · The contract provides up-front and milestone payments of $5 million USD and royalty payments thereafter on Amicogen’s net sales · Bio-Works existing sales in South Korea are less than 1 million SEK per year, which means that the deal is overwhelmingly positive in terms of revenue and financial outcome for 2021The agreement entails a technology transfer from Bio-Works to Amicogen to establish in-country production of chromatography products in

SOTKAMO SILVER AB: YEAR END REPORT 2020

 Press release: Stockholm, February 17, 2021 08.45 CETHIGHLIGHTS OF THE FOURTH QUARTER 2020 · Net sales was 78 MSEK compared to the previous year 86 MSEK due to the lower silver grades in production · EBITDA was 7 MSEK (5) · EBIT was -16 MSEK (-32) · Cash and cash equivalents were 35 MSEK (30) · Investments were 14 MSEK (8) · The production was about 349 000 (418 000) ounces silver, 969 (1 022) ounces gold, 330 (337) tonnes lead, and 757 (611) tonnes zinc in concentrates · Regional State Administrative Agency gave the decision on the environmental permit

The collaboration with Onkos is paving the way for further growth in the US

The collaboration with Onkos is truly starting to pay off. Not only has Onkos recruited a number of well reputed hospitals (among which Emory Healthcare, USC Keck Medical Center, and Duke Health) to the OPRA™ network, these hospitals are now performing their first surgeries with the OPRA™ Implant System and their respective patient treatment plans, and have new patients in the pipeline.Despite the ongoing pandemic, and the subsequent current restrictions placed on elective surgery, these first surgeries have been successfully performed, and further treatments scheduled. Integrum is very

Interim report Q4, 2020

Fourth quarter · Net sales amounted to MSEK 8.4 (0,7) · EBITDA amounted to MSEK -7.2 (-32.6) · EBIT amounted to MSEK -15.2 (-34.9)  · EBT amounted to MSEK –21.2 (-36.9) · SpectrumOne gets trademark protection in the EU · Extraordinary General Meeting held on November 4 · Cloud Explorers in Norway, a subsidiary of SpectrumOne, entered into a full partnership agreement with Bisnode · 95 % of the convertible loan with due date December 30, 2020 was converted into shares at a share price of SEK 3,07 · Chairman, Board member, CEO and other employees subscribe for a

BioStock: Cereno Scientific expands IPR protection to Japan

Last month, Cereno Scientific announced the strengthening of its patent protection for two patent families regarding CS1 in Canada and in Russia. Now, the second family of patents has been strengthened even further as the company on Tuesday announced an expansion of such protection to the Japanese market.Read the full article at biostock.se: https://www.biostock.se/en/cereno-scientific-expands-ipr-protection-to-japan/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

NeoDynamics AB (publ) Full year report 2020

The English text is an unofficial translation of the Swedish report. Commercialization underway Fourth quarter 2020 · Revenue amounted to SEK 3.382 (5.948) m, of which capitalized costs amounted to SEK  2.963 (5.574) m. · Loss after tax amounted to SEK -11.524 (-6.823)) m. · Loss per share amounted to SEK -0.19 (-0.45). Full year 2020 · Revenue amounted to SEK 18.557 (22.277) m, of which capitalized costs amounted to SEK 17.104 (21.787) m. · Loss after tax amounted to SEK -31.006 (-19.415) m. · Loss per share amounted to SEK -0.51 (-1.74). · The equity

Outcome of conversion of Swedish Stirling KV2 and KV3

The conversion period for Swedish Stirling AB’s convertible bonds 2019/2021 (ISIN: SE0012141877) (”KV2”) and convertible bonds 2019/2021:2 (ISIN: SE0013236544) (”KV3”) ended on 15 February 2021. Of the total outstanding loan amount of SEK 79,505,021 under KV2, an amount of SEK 78,814,050 has been requested for conversion, which corresponds to approximately 99 per cent. Under KV3, 100 per cent of the total outstanding loan amount of SEK 53,000,000 has been requested for conversion in accordance with previously received irrevocable undertakings regarding conversion.As a result of the

Fazer commits to the Science Based Targets Initiative

Fazer, The Food Experience company, sees food as a solution. How food is grown, produced and consumed has a significant impact on the environment, on society and on our wellbeing. To further support the implementation of its ambitious sustainability agenda, Fazer has committed to the Science Based Targets Initiative (SBTi). In accordance with the SBT, Fazer will define new climate targets and develop its cooperation model with suppliers to reduce emissions both in own operations and throughout the entire value chain.Fazer has had high ambitions regarding climate actions already for years

Biohit group financial statement release 2020

Biohit Oyj Financial Statement Release 17 February 2021 at 9:30 am local time (EET)   SUMMARY January-December 2020 ·Revenue EUR 7.1 million (EUR 10.1 million) · Revenue decreased by 29.1 % compared to 2019 · Operative EBITDA EUR -1.2 million (EUR +0.6 million) · Cash at the end of the period EUR 1.0 million (EUR 1.3 million) · Fair value of Genetic Analysis AS investment EUR 0.8 million (EUR 3.7 million 31 December 2019) · Revenue from international operations 96.1 % (96.0 %) of total revenue · Equity ratio 80.8 % (83.9 %) July-December 2020 ·

Shape Robotics announces Year-end interim report for 2020

Company Announcement No. 20 - 2021Copenhagen, February 17[th], 2021 This announcement is a summary and should be read in conjunction with Shape Robotics’ Year end interim report, 2020 published on 17 February 2021. The Year-end report for 2020 will be available on the company’s website  and on this link . Financial highlights in 2020The results from the financial year 2020, are in line with the expectations communicated in company announcement

ORGANOCLICK AB (PUBL) PUBLISH YEAR END REPORT FOR 2020

"During the last quarter of the year, our positive sales development continued. Overall, sales increased by 21.3 (14.8) percent to SEK 18.2 (15.0) million. Gross margin (after variable costs) increased to 40.9 (35.2) percent as well after changes to the product mix. Cash flow from operating activities improved significantly to SEK 5.2 (-9.7) million, as a result of good management of the working capital."Translation from CEO Mårten Hellbergs comments to the Interim Report. Q4, 1 October - 31 December 2020 The Group compared with 2019 » Net revenue amounted to SEK 18.20 (15.00)

TagMaster launches app for easy set up of traffic surveys

Press release Stockholm, Sweden, February 17, 2020   TagMaster, the leading supplier of advanced sensor systems for Smart Cities within Traffic and Rail, has developed an app that makes it easy for traffic operators of various kinds to set up and conduct traffic surveys in various environments. The app called EasySetup can be downloaded free of charge from the Google Play Store. EasySetup enables users of TagMaster's traffic monitoring solutions to easily configure TagMaster's various products located in an area or city and quickly conduct traffic surveys. “The app is perfect for

Selvaag Bolig ASA: Key information relating to the cash dividend to be paid

Dividend amount: 3.00 per shareDeclared currency: NOKLast day including right: 29 April 2021Ex-date: 30 April 2021Record date: 3 May 2021Payment date: 14 May 2021Date of approval: 27 April 2021  Further information from:Sverre Molvik, CEO, Selvaag Bolig ASATelephone: +47 40 10 05 85, e-mail: smo@selvaagbolig.no Kristoffer Gregersen, vice president communications and market, Selvaag Bolig ASATelephone: +47 95 77 55 93, e-mail: kgr@selvaagbolig.no   Selvaag Bolig ASA is a residential property developer controlling the entire value chain from acquisition of land

Axactor SE - Acceptances received under mandatory offer

THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Reference is made to the mandatory offer dated 29 January 2021 (the "Mandatory Offer") to acquire all shares in Axactor SE (the "Company") at an offer price of NOK 8.00 per share, made by Geveran Trading Co. Limited, a company indirectly controlled by trusts established by Mr. John Fredriksen for the benefit of his immediate family ("Geveran").  On 16 February 2021,

PPG Industries, Inc. supplements the tender offer document dated January 14, 2021 relating to the voluntary recommended public cash tender offer for all the shares in Tikkurila Oyj

TIKKURILA OYJTender offer February 17, 2021 at 9.o5 a.m. EET NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. PPG Industries, Inc. (“PPG” or the “Offeror”), a corporation incorporated under the laws of Pennsylvania, and Tikkurila Oyj (“Tikkurila” or the “Company”) have on December 18, 2020 entered into a combination agreement (the “Combination Agreement”), which was

SaltX Technology Holding AB Year-end report 2020

FINANCIAL EVENTS  Fourth quarter  -Net sales totaled MSEK 0.0 (0.9) -Operating profit/loss (EBIT) amounted to MSEK -8.1 (-10.9) -Cash flow from operating activities amounted to MSEK -6.7 (-10.2) -Earnings per share before and after dilution were SEK -0.10 (-0.16)  Full year January — December  -Net sales amounted to MSEK 0.1 (0.2) -Operating profit/loss (EBIT) amounted to MSEK -33,4 (-83.8) -Cash flow from operating activities amounted to MSEK -32.5 (-58.8) -Earnings per share before and after dilution were SEK -0.41 (-1.22)  SIGNIFICANTS EVENTS   Fourth

Year-end report 1 January–31 December 2020

fourth QUARTER (1 October–31 December 2020) · Net sales for the quarter amounted to MSEK 26 (247). · Operating profit/loss before depreciation and amortisation (EBITDA) totalled MSEK 1 (147). · Operating profit/loss (EBIT) was MSEK -15 (128). · Comparable profit/loss before tax amounted to MSEK -23 (108) and recognised profit/loss before tax was MSEK -41 (108). · Comparable profit/loss after tax amounted to MSEK -24 (98) and recognised profit/loss after tax was MSEK -42 (98), corresponding to SEK -1.17 (2.93) per share before dilution and SEK -1.17 (2.29) per share after

Salipro Biotech Awarded European Patent for Direct Extraction of Membrane Proteins and Library Generation

Salipro[®] platform technology strengthened to accelerate discovery programs for therapeutic antibodies and small molecule drugs against challenging drug targets Stockholm, Sweden, February 17, 2021 –Swedish biotech company Salipro Biotech AB today announced that the European Patent Office has issued the European Patent No. 3463303, titled “Saposin lipoprotein particles and libraries from crude membranes”. The patent covers the company’s novel method of direct extraction of membrane proteins (DirectMX[TM]) from cells or crude membranes to enable drug development for challenging drug

Finnair completes a lease financing arrangement for its next A350 aircraft delivery

Finnair Plc           Investor News      17 February 2021 at 9.00 EET As a part of Finnair’s rebuild program, the company has finalised a lease financing arrangement for its next A350 aircraft delivery, with JLPS Holding Ireland Limited as the lessor and lease servicer. In the arrangement, Finnair will assign the purchase of the Airbus A350 aircraft to a third party, and then leases it back for its own operation. The aircraft is expected to be delivered to Finnair in the second quarter of 2022. The operating lease period is a minimum of 12 years, including a storage period expected to

Lynparza: IDMC recommend early analysis of OlympiA

17 February 2021 07:00 GMT   IDMC has concluded that OlympiA trial of Lynparza crossed superiority boundary for invasive disease-free survival vs. placebo at planned interim analysis OlympiA Phase III trial of Lynparza in the adjuvant treatment of BRCA-mutated high-risk HER2-negative early breast cancer will be analysed and reported early   The OlympiA Phase III trial for AstraZeneca and MSD's Lynparza will move to early primary analysis and reporting following a recommendation from the Independent Data Monitoring Committee (IDMC).   Based on the planned interim

Last day of trading in warrants of series 2020/2021 is February 17, 2021

Wednesday February 17, 2021 is the last day of trading in warrants of series 2020/2021 in WntResearch AB ("WntResearch" or the "Company"). The exercise period for warrants of series 2020/2021 runs to and including Friday, February 19, 2021. Each warrant gives the right to subscribe for one (1) new share in WntResearch. The exercise price for the warrants is SEK 0.81 per share.Summarized terms for the warrants of series 2020/2021: · Exercise period: February 8, 2021 – February 19, 2021 · Size of issue: 12,685,611 warrants of series 2020/2021. Upon full exercise, 12,685,611 shares

There are no items matching the current filter
There are no more items matching the current filter
Back to top